Literature DB >> 33282018

Cannabis is legal-why are cannabis-based pharmaceuticals still controlled?

Wajd Alkabbani1,2,3, Kevin Friesen1,2,3, Shawn Bugden1,2,3.   

Abstract

Year:  2020        PMID： 33282018      PMCID： PMC7689624          DOI： 10.1177/1715163520960500

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN： 1715-1635


× No keyword cloud information.
  5 in total

1.  Pharmaceutical cannabinoid use in Manitoba, 2004/05 to 2014/15: a population-based cross-sectional study.

Authors:  Wajd Alkabbani; Ruth Ann Marrie; Shawn Bugden; Silvia Alessi-Severini; Paul Daeninck; James Bolton; Jitender Sareen; Christine Leong
Journal:  CMAJ Open       Date:  2018-12-18

2.  A critique of cannabis legalization proposals in Canada.

Authors:  Harold Kalant
Journal:  Int J Drug Policy       Date:  2016-05-13

Review 3.  The abuse potential of the synthetic cannabinoid nabilone.

Authors:  Mark A Ware; Emmanuelle St Arnaud-Trempe
Journal:  Addiction       Date:  2010-03       Impact factor: 6.526

4.  Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study.

Authors:  Wajd Alkabbani; Ruth Ann Marrie; Shawn Bugden; Silvia Alessi-Severini; James M Bolton; Paul Daeninck; Christine Leong
Journal:  Addiction       Date:  2019-07-19       Impact factor: 6.526

5.  Chronic use of tramadol after acute pain episode: cohort study.

Authors:  Cornelius A Thiels; Elizabeth B Habermann; W Michael Hooten; Molly M Jeffery
Journal:  BMJ       Date:  2019-05-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.